Viridian Therapeutics, Inc.\DE (VRDN) Share-based Compensation (2014 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) reported Share-based Compensation of $16.98 million for Q2 2026, up 56.6% from $10.84 million a year earlier and up 26.8% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Viridian Therapeutics, Inc.\DE's Share-based Compensation came in at $53.61 million, up 38.3% year-over-year; for FY2025, it was $44.3 million, up 5.1% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 49.2% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $42.15 million in FY2024 (-37.3%), $67.17 million in FY2023 (+239.9%), $19.77 million in FY2022 (+36.6%) and $14.47 million in FY2021 (+141.1%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q4 2023.
- Year over year, Share-based Compensation has now increased in each of the last four quarters, with growth averaging 2.7% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 547.5%); the low point was Q4 2024 (a decline of 65.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $13.39 million (Q1 2026), $11.99 million (Q4 2025) and $11.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - | 16.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.98 Mn |
| Mar 31, 2026 | 13.39 Mn |
| Dec 31, 2025 | 11.99 Mn |
| Sep 30, 2025 | 11.25 Mn |
| Jun 30, 2025 | 10.84 Mn |
| Mar 31, 2025 | 10.22 Mn |
| Dec 31, 2024 | 8.98 Mn |
| Sep 30, 2024 | 8.72 Mn |
| Jun 30, 2024 | 11.77 Mn |
| Mar 31, 2024 | 12.69 Mn |
| Dec 31, 2023 | 26.05 Mn |
| Sep 30, 2023 | 13.61 Mn |
| Jun 30, 2023 | 12.30 Mn |
| Mar 31, 2023 | 15.22 Mn |
| Dec 31, 2022 | 5.28 Mn |
| Sep 30, 2022 | 4.94 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 4.66 Mn |
| Dec 31, 2021 | 3.49 Mn |
| Sep 30, 2021 | 3.98 Mn |
API Access
Viridian Therapeutics, Inc.\DE Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();